43.500
+0,00%
2026-10-19
Fundamental Analysis
76 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +197.1% | +115.5% | 3 / 3 | +6.2% | +1.63 pp | +3.48 pp | +19.8% | 0.92 | 6.17 | 1.548 | +6,2% | 81,1 | +215,5% | 6.17 | 7.97 | −22,6% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 8 | 6 | 12 | |||||||
Valuation annotation:Price: 43.500 (close price on 2026-10-19)EPS (TTM): 7.056
Financial charts
1.Revenue & growth
VND bn1.548Q2/26
1.Revenue & growth
VND bn1.548Q2/26
2.Profit & growth
VND bn74,8Q2/26
3.Profit mix (Penman)
VND bn267Q2/26
4.Margins & cost structure
%13.8%Q2/26
5.Returns & cash cycle
% · days12.0%Q2/26
6.Earnings quality & cash
VND bn1.325Q2/26
7.Asset structure
VND bn2.714Q2/26
8.Funding & debt health
VND bn · times2.714Q2/26
9.Revenue backlog
VND bn21,2Q2/26
10.Valuation
times · %6,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.076Q2/26
Adjusted EPS growth, latest quarter
197%
Average adjusted EPS growth, 3 quarters
116%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26